Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy

Minghua Yang1, Liying Liu, Min Xie

  • 1a Department of Pediatrics; Xiangya Hospital ; Central South University ; Changsha , Hunan China.

Autophagy
|January 22, 2015
PubMed

Insights

Poly (ADP-ribose) polymerase 1 (PARP1) regulates high mobility group box 1 (HMGB1) in cancer cells, influencing autophagy and apoptosis. This pathway impacts sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TNFSF10/TRAIL) therapy.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Apoptosis and autophagy are key cell death pathways with crosstalk influencing cancer drug response.
  • The precise mechanisms governing this crosstalk, particularly in response to specific cancer therapies, remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of high mobility group box 1 (HMGB1) in tumor necrosis factor [ligand] superfamily, member 10 (TNFSF10)-induced cancer cell death.
  • To investigate the involvement of poly [ADP-ribose] polymerase 1 (PARP1) in regulating HMGB1-mediated cell death pathways.

Main Methods:

  • Investigated the role of PARP1 in TNFSF10-induced cancer cell death using pharmacological inhibition and gene knockdown.
  • Assessed HMGB1 ADP-ribosylation, cytoplasmic translocation, and complex formation with BECN1.
  • Evaluated the impact of modulating the PARP1-HMGB1 pathway on autophagy, apoptosis, and TNFSF10 anticancer activity in vitro and in vivo.

Main Results:

  • PARP1 activation was essential for TNFSF10-induced HMGB1 ADP-ribosylation and subsequent cytoplasmic translocation.
  • Inhibition or knockdown of PARP1 reduced HMGB1-BECN1 complex formation, diminished autophagy, and increased apoptosis.
  • Suppression of the PARP1-HMGB1 pathway enhanced the anticancer efficacy of TNFSF10.

Conclusions:

  • PARP1 is a critical upstream regulator of HMGB1-mediated autophagy in cancer cells.
  • The PARP1-HMGB1 axis plays a key role in maintaining the balance between apoptosis and autophagy.
  • Understanding this pathway offers new insights into mechanisms of TNFSF10 resistance and potential therapeutic strategies.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.5K